Pandemic-related disruptions in cancer screening showed an uneven recovery in 2023, data from the National Health Interview ...

Researchers examined screening rates for three kinds of cancer before, during, and after the COVID-19 pandemic.

Despite a proven survival benefit, the addition of pembrolizumab (Keytruda) to chemoradiotherapy for newly diagnosed locally ...

From 2008 to 2022, rates for precancerous lesions decreased about 80 percent among 20- to 24-year-old women who were screened ...

Breast and colon cancer screening numbers have since rebounded and have even surpassed pre-pandemic screening estimates, a ...

From 2008 to 2022, the incidence of cervical precancers fell by 80% among screened women aged 20 to 24 years, supporting ...

A recent CDC report further demonstrates the effectiveness of the HPV vaccine against cervical cancer. HPV is a sexually ...

Bandi and her team found that past-year cervical cancer screenings in 2023 remained at 14%, which is below pre-pandemic ...

Preventive screenings for cancer declined during the pandemic, with lockdowns, social distancing and COVID-19 surges ...

The Department of Health is rolling out the first round of HPV vaccinations for girls between the ages of 9 and 14 until ...

Colorectal cancer screening increased 12% and breast cancer screening increased 7% between 2019 and 2023. Cervical cancer screening remained 14% below rates from 2019, neither increasing or decreasing ...

As part of the Ontario Cervical Screening Program, the province has announced it is going to use Human Papillomavirus (HPV) testing rather than Pap smear tests as a primary way to screen for cervical ...